Abstract:Purpose: Recently, emerging evidences have shown that microbiome might play an important role in the pathogenesis of osteoarthritis (OA). Previously, we have proposed a two-hit model of OA pathogenesis and potentiation in which shifts of gut microbiome acted the innate immune response as one hit. Another hit results from joint damage that releases a lot of damage associated with molecular patterns (DAMPs), resulting in a synergistic activation of inflammatory pathways leading to OA. The current study was aimed to prove our two-hit hypothesis. Methods: Basic information, fecal and blood samples were collected in three different groups of people: health control, OA without metabolic syndrome (MS), OA with metabolic syndrome. Low-density lipoprotein (LDL), high-density lipoprotein (HDL), triglyceride (TG) and cholesterol (CHOL) were detected in the blood samples. 16S RNA sequencing was used to profile the composition of microbiome in fecal samples and compared in groups. Based on different types of fecal transplantation and surgical treatments, thirty-nine germ free mice were divided into following groups: 1) Group 1: transplanted with sterile water for 7 days then MLI model was induced; 2) Group 2: transplanted with fecal samples from people of health control group and sham surgery was induced; 3) Group 3: transplanted with fecal samples from people of health control group and MLI model was induced; 4) Group 4: transplanted with fecal samples from patients of OA without MS group and MLI model was induced; 5) Group 5: transplanted with fecal samples from patients of OA with MS group and MLI model was induced. Mice were sacrificed 6 weeks following surgery. All the knee joints, blood samples, small intestine and colon were collected. Customized inflammatory biomarkers panel (Milliplex®) was used to detect inflammatory biomarkers in the blood samples. Also, lipopolysaccharide (LPS) and lipopolysaccharide binding protein were also detected in the blood samples. Knee joints were processed for histology analysis and stained in Safranin O for OARSI scoring. 16S RNA sequencing was applied in fecal samples collected from both small intestine and colon for microbiome profiling and compared in groups. FISH was used to visualize the change of permeability of colonic mucosa. Data were analyzed using Kruskal-Wallis test. Spearman correlations were calculated between inflammatory biomarkers, OARSI scores and microbiome profiles. Results: Totally nineteen patients were recruited, 4 in the health control group, 7 in the OA without MS group and 8 in the OA with MS group. Significant higher BMI (p<0.001), LDL (p=0.007) and TG level (p=0.015) were founded in the OA with MS group. Significant lower HDL level was found in the OA with MS group compared to the other two groups (p=0.034). Microbiome profile showed no significant differences between three groups in terms of αdiversity. While significant differences in terms of β diversity was found (p=0.036). Histology analysis of the mice knee joints showed significant lower OARSI score in Group 1 and Group 2 compared with the other three groups (Figure 1). While Group 5 has the highest OARSI score compared with Group 3 and 4 (Figure 1). Inflammatory biomarkers analysis showed significant higher IL-1βand MCP-1 were founded in Group 5 (Figure 2). Significant lower αdiversity of microbiome was found in Group 5. While significant differences in terms of β diversity was also founded between groups. Correlations between OARSI score, biomarkers and microbiome profile showed that both Anaerostipes and Fusobacterium had significant positive correlations with inflammatory biomarkers and histological severity. Also Fusobacterium had a significant negative correlation with inflammatory biomarkers and histological severity. Conclusions: 1) Germ-free will alleviate the severity of OA in mice model; 2) IL-1βand MCP-1 might play an important role in germ-free protection; 3) Anaerostipes and Fusobacterium might be the cause of the MS associated OA. While Fusobacterium can protect people from MS associated OA. Further mechanism needs future explorations.View Large Image Figure ViewerDownload Hi-res image Download (PPT)

Potential efficacy of gut microbiome dysbiosis on alleviation the progress of osteoarthritis in mice

Gut Microbiome Dysbiosis Alleviates He Progression Of Osteoarthritis In Mice

Gut microbiome dysbiosis alleviates the progression of osteoarthritis in mice

Gut Microbiome Dysbiosis Alleviate the Progress of Osteoarthritis in Mice

Microbiome dysbiosis by antibiotics protects cartilage degradation in OAOP mice

OSTEOARTHRITIS INDUCED BY MENISCAL/LIGAMENTOUS INJURY IS AGGRAVATED AFTER METABOLIC SYNDROME FECAL SAMPLE TRANSPLANTATION IN GERM-FREE MICE

Gut Microbiota Modulates Osteoclast Glutathione Synthesis and Mitochondrial Biogenesis in Mice Subjected to Ovariectomy

Faecal microbiota transplantation from metabolically compromised human donors accelerates osteoarthritis in mice

Association Between Gut Microbiota and Osteoarthritis: A Review of Evidence for Potential Mechanisms and Therapeutics

Gut-microbiota modulation: The impact of thegut-microbiotaon osteoarthritis

Altered gut microbiome profile in patients with knee osteoarthritis

Gut-joint axis: Oral Probiotic ameliorates Osteoarthritis

Dysbiosis of the Gut Microbiome is a Risk Factor for Osteoarthritis in Older Female Adults: a Case Control Study

Prebiotics alleviate cartilage degradation and inflammation in post-traumatic osteoarthritic mice by modulating the gut barrier and fecal metabolomics

Antibiotic Treatment Prior to Injury Improves Post-Traumatic Osteoarthritis Outcomes in Mice

The gut microbiota in osteoarthritis: where do we stand and what can we do?

"Cross-talk" between gut microbiome dysbiosis and osteoarthritis progression: a systematic review

Oral administration of live combined Bacillus subtilis and Enterococcus faecium alleviates colonic oxidative stress and inflammation in osteoarthritic rats by improving fecal microbiome metabolism and enhancing the colonic barrier

The Complex Interplay between the Gut Microbiome and Osteoarthritis: A Systematic Review on Potential Correlations and Therapeutic Approaches

Oral administration of live combined <i>Bacillus subtilis</i> and <i>Enterococcus faecium</i> alleviates colonic oxidative stress and inflammation in osteoarthritic rats by improving fecal microbiome metabolism and enhancing the colonic barrier

The Gut Microbiota of Rats under Experimental Osteoarthritis and Administration of Chondroitin Sulfate and Probiotic